News and Announcements
SUDA’s Annual Report to Shareholders
- Published October 02, 2015 2:17PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
30th September 2015, ASX Announcement
Like most listed entities the Board of SUDA is focused on “creating sustainable value for shareholders”. Your Board has spent considerable time ensuring management has a very clear understanding of the building blocked required to “create sustainable value”.
Our key building blocks are designed to:
- Build a global reputation for innovation and excellence in oro-mucosal drug delivery;
- Execute licence deals and trade sales to generate upfront, milestone and royalty payments;
- Create strategic alliances and partnerships through scientific collaboration;
- Expand our patent portfolio and product pipeline;
- Build investor community awareness and manage expectations;
- Comply with best practice corporate governance and financial management; and
- Build flexible and responsive management.
Under each of these building blocks the management team has specific work plans and budgets and is accountable to the CEO, and in turn, to the Board.
To view the full announcement, please click here.